| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,867 | $28.17 | $221,636.99 | -100% | -40.9% | +15.2% | |
| Feb 4, 2025 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 300 | $585.59 | $175,677.00 | -1.8% | -27.3% | -2.6% | |
| Feb 4, 2025 | CDNA Caredx, Inc. | Novack Jeffrey Adam68 | Secretary And General Counsel | Sell | 3,512 | $23.30 | $81,829.25 | -3.2% | -34.3% | -18.1% | |
| Feb 4, 2025 | TMO Thermo Fisher Scientific Inc. | Williamson Stephen68 | Sr. VP And CFO | Sell | 19,650 | $589.36 | $11,580,924.00 | -26.5% | -27.3% | -2.6% | |
| Feb 4, 2025 | IMDX Insight Molecular Diagnostics Inc. | Smith Patrick W66 | 10% Owner | Buy | 915 | $2.01 | $1,839.40 | - | +37.1% | +211.7% | |
| Feb 3, 2025 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 806 | $49.35 | $39,777.71 | -0.7% | -31.9% | -12.2% | |
| Feb 3, 2025 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,845 | $49.35 | $140,406.44 | -1.0% | -31.9% | -12.2% | |
| Feb 3, 2025 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 185 | $49.35 | $9,130.12 | -0.3% | -31.9% | -12.2% | |
| Feb 3, 2025 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 1,259 | $49.35 | $62,134.17 | -0.9% | -31.9% | -12.2% | |
| Feb 3, 2025 | VCYT Veracyte, Inc. | Chambers Rebecca73 | Chief Financial Officer | Sell | 527 | $43.85 | $23,108.95 | -0.5% | -30.5% | -16.2% | |
| Feb 3, 2025 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 5,200 | $49.35 | $256,630.40 | -0.8% | -31.9% | -12.2% | |
| Feb 3, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 43,902 | $176.85 | $7,763,862.19 | -8.7% | -10.9% | +29.0% | |
| Feb 3, 2025 | NOTV Inotiv, Inc. | Krupp Jeffrey Arthur | Chief Human Resources Officer | Sell | 2,508 | $4.42 | $11,096.07 | -4.2% | -54.0% | -89.2% | |
| Jan 31, 2025 | NOTV Inotiv, Inc. | Leasure Robert Jr.63 | President And CEO | Sell | 22,700 | $4.15 | $94,298.07 | -2.2% | -53.7% | -88.3% | |
| Jan 31, 2025 | NOTV Inotiv, Inc. | Taylor Beth54 | Chief Financial Officer | Sell | 2,054 | $4.47 | $9,171.11 | -1.8% | -53.7% | -88.3% | |
| Jan 31, 2025 | NOTV Inotiv, Inc. | Sagartz John E60 | Chief Strategy Officer | Sell | 2,118 | $4.48 | $9,478.90 | -0.3% | -53.7% | -88.3% | |
| Jan 31, 2025 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,217 | $167.31 | $203,612.70 | -0.2% | -14.4% | +30.6% | |
| Jan 31, 2025 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 6,221 | $169.12 | $1,052,112.05 | -1.2% | -14.4% | +30.6% | |
| Jan 30, 2025 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 15,170 | $126.73 | $1,922,512.90 | -8.6% | -26.3% | -14.2% | |
| Jan 30, 2025 | DHR Danaher Corp /de/ | Ellis Brian W62 | Senior Vice President - GC | Sell | 5,700 | $224.13 | $1,277,541.00 | -22.0% | -10.6% | -1.9% | |
| Jan 30, 2025 | IMDX Insight Molecular Diagnostics Inc. | Smith Patrick W66 | 10% Owner | Buy | 4,198 | $2.01 | $8,437.98 | +0.1% | +53.2% | +224.4% | |
| Jan 29, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 13,685 | $165.87 | $2,269,928.10 | -1.3% | -7.9% | +37.6% | |
| Jan 29, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 6,003 | $165.87 | $995,715.77 | -0.1% | -7.9% | +37.6% | |
| Jan 29, 2025 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 4,030 | $165.87 | $668,453.90 | -0.9% | -7.9% | +37.6% | |
| Jan 29, 2025 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 4,773 | $165.87 | $791,693.97 | -0.7% | -7.9% | +37.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.